TABLE 1.
Antibiotic resistance of serotypes of PNSSP IMPACT study isolates
| Drug | No. of resistant isolates of serotype:
|
||||||
|---|---|---|---|---|---|---|---|
| 6B (n = 7, 16%) | 9V (n = 11, 24%) | 14 (n = 11, 24%) | 19A (n = 1, 2%) | 19F (n = 4, 10%) | 23F (n = 11, 24%) | Total (n = 45, 100%) | |
| Penicillin | 0 (7 Ia) | 7 (4 I) | 4 (7 I) | 1 | 1 (3 I) | 9 (2 I) | 22 (49%) (23 I) |
| Erythromycin | 3 | 0 | 2 | 1 | 1 | 6 | 13 (29%) |
| SXT | 6 | 11 | 10 | 1 | 3 | 1 | 42 (93%) |
| Chloramphenicol | 1 | 0 | 9 | 0 | 0 | 10 | 20 (44%) |
| Tetracycline | 1 (1 I) | 0 | 1 | 0 | 3 | 8 | 13 (29%) (1 I) |
| Clindamycin | 1 | 0 | 1 | 1 | 1 | 5 | 9 (20%) |
| Rifampin | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ofloxacin | 0 | 0 | 0 | 0 (1 I) | 0 (1 I) | 1 (1 I) | 1 (3 I) |
| Meropenem | 0 | 0 (8 I) | 0 (3 I) | 0 | 0 | 0 (6 I) | 0 (17 I) |
| Cefuroxime | 4 | 8 | 5 | 1 | 3 (1 I) | 11 | 32 (71%) (1 I) |
| Cefotaxime | 0 (4 I) | 0 (7 I) | 0 (3 I) | 0 (1 I) | 0 | 0 (6 I) | 0 (21 I) |
| 2 drugs | 6 | 11 | 11 | 1 | 3 | 12 | 43 (95%) |
| ≥3 drugs | 4 | 3 | 3 | 1 | 3 | 11 | 25 (55%) |
a
I, intermediate susceptibility.